Time (months)

FPG (mmol/L)

A1C (%)

Group A (n = 20)

Group B (n = 19)

Group A (n = 20)

Group B (n = 19)

Control Phase

0

12.23 ± 2.37

12.80 ± 2.60

8.88 ± 1.35

9.41 ± 1.50

3

2.00 ± 2.32

13.87 ± 3.54

8.38 ± 1.24

9.35 ± 1.86

Treatment Phase

5

11.56 ± 2.59

12.53 ± 4.06

9.58 ± 1.94

9.93 ± 2.25

7

11.79 ± 2.49

12.41 ± 3.25

9.39 ± 1.69

10.01 ± 2.13

9

11.88 ± 2.50

12.13 ± 2.70

8.94 ± 2.04

9.21 ± 3.18

11

12.69 ± 2.55

12.97 ± 3.21

9.36 ± 1.75

9.51 ± 1.79

13

12.83 ± 2.59

13.01 ± 3.14

9.26 ± 2.19

9.57 ± 1.89

Two-way ANOVA

p < 0.001

NS

p < 0.05

NS